ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7%

January 28, 1977

NSABP Sees Groups To Join Breast Cancer Prevention Trial

September 27, 1991

Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack

January 8, 1993

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program

October 24, 1975

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987